Related Experiment Video
Updated: Aug 18, 2026

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
Published on: February 20, 2020
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer
Norio Ohmagari1, Hend Hanna, Linda Graviss
1Division of Infectious Diseases, Shizuoka Cancer Center, Shizuoka, Japan.
Background:
Pseudomonas aeruginosa is responsible for a wide range of infections. In immunocompromised patients with cancer, the emergence of multidrug resistant P. aeruginosa may have grave consequences.
Methods:
Patients with cancer who were infected with multidrug-resistant P. aeruginosa with polyclonal DNA restriction patterns were used as the case group. Two control groups were used: one group of cancer patients who were infected with multidrug-susceptible P. aeruginosa and another group of cancer patients who had the same underlying disease and the same intensive care unit exposure as patients in the case group but who were not infected or colonized by P. aeruginosa.
Results:
Risk factors that were associated significantly with multidrug-resistant P. aeruginosa infection were the use of carbapenem for > or = 7 days, a history of P. aeruginosa infection during the preceding year, and a history of chronic obstructive pulmonary disease (P < 0.01).
Conclusions:
Carbapenems may need to be used more judiciously as first-line empirical therapy for cancer patients with prior pseudomonal infection or chronic obstructive pulmonary disease who require hospitalization, and alternative, antipseudomonal antibiotic regimens may need to be considered, especially in this patient population.
Insights
Multidrug-resistant Pseudomonas aeruginosa infections pose a significant threat to cancer patients. Prolonged carbapenem use and prior P. aeruginosa infection are key risk factors for these dangerous infections.
Area of Science:
- Infectious Diseases
- Oncology
- Antimicrobial Resistance
Background:
- Pseudomonas aeruginosa causes diverse infections, with multidrug-resistant strains posing severe risks to immunocompromised cancer patients.
- The emergence of multidrug-resistant P. aeruginosa (MDRP) in cancer patients can lead to grave outcomes.
Purpose of the Study:
- To identify risk factors associated with multidrug-resistant P. aeruginosa infections in cancer patients.
- To inform strategies for preventing and managing MDRP infections in this vulnerable population.
Main Methods:
- A case-control study design was employed.
- Cases were cancer patients with MDRP infections (polyclonal DNA patterns).
- Controls included cancer patients with multidrug-susceptible P. aeruginosa infections and uninfected/uncolonized cancer patients with similar ICU exposure.
Main Results:
- Significant risk factors for MDRP infection included carbapenem use for ≥7 days (P < 0.01).
- A history of P. aeruginosa infection within the preceding year was also a significant risk factor (P < 0.01).
- Chronic obstructive pulmonary disease (COPD) was identified as a significant risk factor (P < 0.01).
Conclusions:
- Judicious use of carbapenems as first-line empirical therapy is recommended for cancer patients, particularly those with a history of P. aeruginosa infection or COPD.
- Alternative antipseudomonal antibiotic regimens should be considered for high-risk cancer patients requiring hospitalization.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

